Overexpression of p53 protein and DNA content are important biologic prognostic factors for thyroid cancer

被引:31
作者
Nishida, T
Nakao, F
Hamaji, M
Nakahara, M
Tsujimoto, M
机构
[1] OSAKA POLICE HOSP,DEPT SURG,OSAKA,JAPAN
[2] OSAKA POLICE HOSP,DEPT PATHOL,OSAKA,JAPAN
关键词
D O I
10.1016/S0039-6060(96)80269-8
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background. Many factors have been reported to be of prognostic importance for thyroid cancer. Biologic aggressiveness may influence postoperative recurrences and the prognosis of thyroid cancer Immunohistochemical staining for the p53 protein and DNA content are novel factors that suggest biologic aggressiveness. Methods. Retrospective study of the survival rate after operation of differentiated thyroid cancer was undertaken at Osaka Police Hospital. Age, gender, operative method, extent of lymph node dissection, use of radioiodine, primary or recurrent Armor, tumor tumor size and invasion lymph node involvement, presence of distant metastases, DNA ploidy percentage of S phase and G2M phase fractions, positive staining for the p53 protein, and histologic type and subtype were evaluated as possible Prognostic factors by univariate and multivariate analyses of survival. Results. Positive staining for the p53 protein was related to postoperative local recurrence, and DNA ploidy was related to distant metastatic recurrence. Univariate analysis suggested that age, tumor size and invasion, lymph node involvement, presence of distant metastases, percentage of S phase fraction, histologic subtype, DNA ploidy, and positive staining ow the p53 protein were significant prognostic factors. Multivariate analysis suggested that positive staining of the protein and DNA ploidy were independent prognostic factors for overall survival. Conclusions. Both positive staining for the p53 protein and DNA ploidy which suggest biologic aggressiveness, are independent prognostic factors for overall survival of patients with thyroid cancer. Examination of these biologic factors may provide new information regarding postoperative recurrences and the prognosis of thyroid cancer.
引用
收藏
页码:568 / 575
页数:8
相关论文
共 53 条
[1]   EXPRESSION OF ONCOGENES IN THYROID-TUMORS - COEXPRESSION OF C-ERBB2/NEU AND C-ERBB [J].
AASLAND, R ;
LILLEHAUG, JR ;
MALE, R ;
JOSENDAL, O ;
VARHAUG, JE ;
KLEPPE, K .
BRITISH JOURNAL OF CANCER, 1988, 57 (04) :358-363
[2]  
AKSLEN LA, 1993, CANCER, V72, P2680, DOI 10.1002/1097-0142(19931101)72:9<2680::AID-CNCR2820720926>3.0.CO
[3]  
2-D
[4]   CHROMOSOME-17 DELETIONS AND P53 GENE-MUTATIONS IN COLORECTAL CARCINOMAS [J].
BAKER, SJ ;
FEARON, ER ;
NIGRO, JM ;
HAMILTON, SR ;
PREISINGER, AC ;
JESSUP, JM ;
VANTUINEN, P ;
LEDBETTER, DH ;
BARKER, DF ;
NAKAMURA, Y ;
WHITE, R ;
VOGELSTEIN, B .
SCIENCE, 1989, 244 (4901) :217-221
[5]  
CADY B, 1988, SURGERY, V104, P947
[6]  
CAMPO E, 1991, CANCER RES, V51, P4436
[7]   SINGLE MISSENSE MUTATION IN THE TYROSINE KINASE CATALYTIC DOMAIN OF THE RET PROTOONCOGENE IS ASSOCIATED WITH MULTIPLE ENDOCRINE NEOPLASIA TYPE 2B [J].
CARLSON, KM ;
DOU, SS ;
CHI, D ;
SCAVARDA, N ;
TOSHIMA, K ;
JACKSON, CE ;
WELLS, SA ;
GOODFELLOW, PJ ;
DONISKELLER, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (04) :1579-1583
[8]   PROGNOSTIC VALUE AND CLINICOPATHOLOGICAL CORRELATION OF P53 GENE-MUTATIONS AND NUCLEAR-DNA CONTENT IN HUMAN LUNG-CANCER - A PROSPECTIVE-STUDY [J].
CASSON, AG ;
MCCUAIG, S ;
CRAIG, I ;
AYED, A ;
INCULET, R ;
KERKVLIET, N ;
OMALLEY, F .
JOURNAL OF SURGICAL ONCOLOGY, 1994, 56 (01) :13-20
[9]   FOLLICULAR AND HURTHLE CELL-CARCINOMA OF THE THYROID [J].
COOPER, DS ;
SCHNEYER, CR .
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 1990, 19 (03) :577-591
[10]  
COX DR, 1972, J R STAT SOC B, V34, P187